138 related articles for article (PubMed ID: 34363132)
1. Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68-69.
Bucchi L; Ravaioli A; Baldacchini F; Giuliani O; Mancini S; Vattiato R; Rossi PG; Campari C; Canuti D; Di Felice E; de Bianchi PS; Ferretti S; Bertozzi N; Falcini F;
Eur Radiol; 2022 Feb; 32(2):834-841. PubMed ID: 34363132
[TBL] [Abstract][Full Text] [Related]
2. Incidence of interval breast cancer among women aged 45-49 in an organised mammography screening setting.
Bucchi L; Ravaioli A; Baldacchini F; Giuliani O; Mancini S; Vattiato R; de Bianchi PS; Ferretti S; Falcini F
J Med Screen; 2021 Jun; 28(2):207-209. PubMed ID: 32842856
[TBL] [Abstract][Full Text] [Related]
3. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
4. Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen.
Ravaioli A; Foca F; Colamartini A; Falcini F; Naldoni C; Finarelli AC; de Bianchi PS; Bucchi L
BMC Med; 2010 Feb; 8():11. PubMed ID: 20122145
[TBL] [Abstract][Full Text] [Related]
5. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
6. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.
Foca F; Mancini S; Bucchi L; Puliti D; Zappa M; Naldoni C; Falcini F; Gambino ML; Piffer S; Sanoja Gonzalez ME; Stracci F; Zorzi M; Paci E;
Cancer; 2013 Jun; 119(11):2022-8. PubMed ID: 23504860
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
8. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.
Moorman SEH; Pujara AC; Sakala MD; Neal CH; Maturen KE; Swartz L; Egloff H; Helvie MA
AJR Am J Roentgenol; 2021 Jul; 217(1):40-47. PubMed ID: 33955776
[No Abstract] [Full Text] [Related]
9. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts.
Bucchi L; Ravaioli A; Foca F; Colamartini A; Falcini F; Naldoni C;
J Med Screen; 2008; 15(1):30-5. PubMed ID: 18416953
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
11. Quality control of mammography screening in the Veneto Region. Evaluation of four programs at a local health unit level--analysis of the frequency and diagnostic pattern of interval cancers.
Vettorazzi M; Stocco C; Chirico A; Recanatini S; Saccon S; Mariotto R; Cinquetti S; Moretto T; Sartori P; Stomeo A; Ciatto S
Tumori; 2006; 92(1):1-5. PubMed ID: 16683376
[TBL] [Abstract][Full Text] [Related]
12. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Canelo-Aybar C; Posso M; Montero N; Solà I; Saz-Parkinson Z; Duffy SW; Follmann M; Gräwingholt A; Giorgi Rossi P; Alonso-Coello P
Br J Cancer; 2022 Mar; 126(4):673-688. PubMed ID: 34837076
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
14. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
15. The natural history of invasive breast cancers detected by screening mammography.
Zahl PH; Maehlen J; Welch HG
Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
[TBL] [Abstract][Full Text] [Related]
16. Monitoring interval cancers in an Australian mammographic screening programme.
Kavanagh AM; Mitchell H; Farrugia H; Giles GG
J Med Screen; 1999; 6(3):139-43. PubMed ID: 10572844
[TBL] [Abstract][Full Text] [Related]
17. Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland.
Parvinen I; Chiu S; Pylkkänen L; Klemi P; Immonen-Räihä P; Kauhava L; Malila N; Hakama M
Br J Cancer; 2011 Oct; 105(9):1388-91. PubMed ID: 21934688
[TBL] [Abstract][Full Text] [Related]
18. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
19. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
